Femasys is trading at $2.22, down -5.53%, as its announced $30 million private placement raises dilution concerns.

  • The financing includes shares and warrants and substantial potential share issuance, creating dilution concerns for existing shareholders.
  • The decline is occurring despite stronger broader markets, with the S&P 500 up 0.59% and Nasdaq up 0.86%.
  • Femasys is scheduled to report second-quarter results on August 14, 2026, adding near-term uncertainty.